Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-10-06
2011-11-22
Hartley, Michael G (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S023000, C514S056000, C514S061000, C514S618000, C424S771000, C435S007310
Reexamination Certificate
active
08063026
ABSTRACT:
Provided herein are methods of using mannan oligosaccharides, to treat, palliate, relieve, prevent and/or eliminate urinary tract infections of humans. A mixture of oligosaccharides derived from yeast cell walls is shown to reduce, eliminate and prevent the symptoms of UTI in patients.
REFERENCES:
patent: 5939279 (1999-08-01), Smith et al.
patent: 6143300 (2000-11-01), Stevenot
patent: 6753319 (2004-06-01), Benedict et al.
patent: 7048937 (2006-05-01), Dawson et al.
Davis, M.E., et al., “Dietary supplementation with phosphorylated mannans improves growth response and modulates immune function of weanling pigs”, 2004, Journal of Animal Science, 82, pp. 1882-1891.
Parkkinen, J., eta;., “Identification of factors in human urine that inhibit the binding of E. Coli adhesions”, 1988, Infection and Immunity, 56:10, pp. 2623-2630.
Aronson, M., et al., Prevention of colonization of the urinary tract of mice with E. Coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside, 1979, 139:3, pp. 329-332.
Wright, J.V., et al., “D-Mannose and Bladder Infection”, 2001, d-mannoseworks.com, pp. 1-16.
Abraham, D.J, et al., “Swainsonine affects the processing of glycoproteins in vivo”, 1983, FEBS, 163(1), pp. 110-113.
Halasz, A., et al., “Use of Yeast Biomass in Food Production”, 1991, CRC Press, p. 31.
Health Marketplace Website, Accessed by internet archive, “http://web.archive.org/web/20040805135721/http://www.health-marketplace.com/Probiotic-Blend.htm” Aug. 5, 2004, pp. 1-2.
Head, K.A., et al., “Natural Approaches to Prevention and Treatment of Infections of the Lower Urinary Tract”, 2008, Alternative Medicine Review, 13, pp. 227-244.
Foxman, B., et al. 2000. Ann. Epidemiol. 10:509-15.
Manges, et al. 2001. NEJM, 345:1007-1013.
Sotelo, TM and Westney, OL, 2004. “Recurrent UrinaryTract Infections in women”; Women's Healthcare, pp. 2-6.
Stamm and Wooten, 1993. NEJM 329:1328.
Gupta, et al. 1999. JAMA 281:736-738.
Shibata,N., et al. 1996. JBC 271-9259.
Okawa, Y, et al. 2006. Biol. Pharm. Bull. 29:388.
Shibata, N., et al. 1996. Arch.Biochem Biophys. 336:49.
Rozeboom, et al. 2005. J. Anim. Sci. 83:2637.
Holland, 1990. Clin Microb. Rev. 3:345.
Stewart, et al. Rec. Dev. in Pig Nutrition, “Recent Advances in Probiosis in Pigs: Observ. on the Microbio.of the Pig Gut”, pp. 51-77, Nottingham Univ. press, Nottinham,UK.
Spring, et al., 2000. Poult. Sci. “The Effects of Dietary Mannanoligosaccharides on Cecal Parametes . . . ” 79:205.
Savage and Zakrzewska, 1996. Poul. Sci. “The Performance of Male Turkeys Fed a Starter . . . ” pp. 47-54.
Peppler, H.J., 1979. Microbial Technology & Microbial Processes, vol. 1 (2nd Ed.) “Production of Yeasts and Yeast Products.” p. 157.
Feiz, L., et al. 2006. Plant Methods “Evaluation of cell wall preparations for purifying ell walls fromArabidopsishypocotyls” 2:10.
Davis, et al. 2004. J. Anim. Sci. “Dietary Supplementation with phosphorylated mannans improves . . . ” 82:1882.
Whistler, RI and J Saarnio Galactomannan from soy Bean Hulls 1957 J. Am. Chem. Soc. 79:6055-6057.
McCleary, BV Enzymatic Hydrolysis, Fine Structure, and Gelling Interaction of Legum-Seed D-Galacto-D-Mannans 1979 Carbo. Res. 71:205-230.
Stephen Barrett, MD, The American Quack Association (http://www.quackwatch.com/04ConsumerEducation/Nonrecorg/aqa.html).
Weiner, MH and WJ Yount, Mannnan Antigenemia in the Diagnosis of Invasive Candida Infections, 1976 J. Clin. Invest. 58:1045-53.
Kilpatrick, DC, Mannan-Binding Lectin: Clinical Significance and Applications 2002 Biochim. et Biophys. Acta 1572:401-413.
Beutler, E. and L. Teeple, Mannose Metabolism in the Human Erythrocyte, J. Clin. Invest. 1969 48:461-466.
Dolberg David
Hartley Michael G
Rider Lance
LandOfFree
Method of palliating lower urinary tract infections by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of palliating lower urinary tract infections by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of palliating lower urinary tract infections by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4310095